ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-23E10388
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2022
BUY CHAPTERS

Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Research Report 2025

Code: QYRE-Auto-23E10388
Report
February 2025
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Amgen Inc
Biocon Ltd.
Cadila Pharmaceuticals
Dr. Reddy’s Laboratories
Emcure Pharmaceuticals
Intas Pharmaceuticals
Kyowa Kirin
Novartis
Pfizer Inc
Reliance Life Sciences
Harbin Pharmaceutical
North China Pharmaceutical
Kexing Biopharm
Qilu Pharmaceutical
Quangang Pharmaceutical
Sunway Biotech
SL Pharmaceutical
Four Rings Bio-Pharmaceutical
Amoytop
Wuzhong Pharmaceutical
Arven Pharmaceuticals
Jiuyuan Gene

Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market

Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market

The global market for Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF).
The Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Report

Report Metric Details
Report Name Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Amgen, Arven Pharmaceuticals, Biocon, Cadila Pharmaceuticals, Dr.Reddy's Laboratories, Emcure Pharmaceuticals, Intas Pharmaceuticals, Kyowa Kirin, Novartis, Pfizer, Reliance Life Sciences, Harbin Pharmaceutical, North China Pharmaceutical, Jiuyuan Gene, Kexing Biopharm, Qilu Pharmaceutical, Quangang Pharmaceutical, Sunway Biotech, SL Pharmaceutical, Four Rings Bio-Pharmaceutical, Amoytop, Wuzhong Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market report?

Ans: The main players in the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market are Abbott, Amgen, Arven Pharmaceuticals, Biocon, Cadila Pharmaceuticals, Dr.Reddy's Laboratories, Emcure Pharmaceuticals, Intas Pharmaceuticals, Kyowa Kirin, Novartis, Pfizer, Reliance Life Sciences, Harbin Pharmaceutical, North China Pharmaceutical, Jiuyuan Gene, Kexing Biopharm, Qilu Pharmaceutical, Quangang Pharmaceutical, Sunway Biotech, SL Pharmaceutical, Four Rings Bio-Pharmaceutical, Amoytop, Wuzhong Pharmaceutical

What are the Application segmentation covered in the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market report?

Ans: The Applications covered in the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market report are Myelosuppressive Chemotherapy, Leukemia Chemotherapy, Others

What are the Type segmentation covered in the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market report?

Ans: The Types covered in the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market report are Vials, Prefilled

Recommended Reports

Recombinant Proteins & Injections

Cancer & Hematology Therapies

Cell & Gene Therapies

1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Overview
1.1 Product Definition
1.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Type
1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vials
1.2.3 Prefilled
1.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Application
1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Value by Application (2024 VS 2031)
1.3.2 Myelosuppressive Chemotherapy
1.3.3 Leukemia Chemotherapy
1.3.4 Others
1.4 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue 2020-2031
1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales 2020-2031
1.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Competition by Manufacturers
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Date of Enter into This Industry
2.8 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Players Market Share by Revenue
2.8.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Scenario by Region
3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region: 2026-2031
3.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region: 2026-2031
3.4 North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Facts & Figures by Country
3.4.1 North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Arven Pharmaceuticals
6.3.1 Arven Pharmaceuticals Company Information
6.3.2 Arven Pharmaceuticals Description and Business Overview
6.3.3 Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.3.5 Arven Pharmaceuticals Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Company Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Cadila Pharmaceuticals
6.5.1 Cadila Pharmaceuticals Company Information
6.5.2 Cadila Pharmaceuticals Description and Business Overview
6.5.3 Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.5.5 Cadila Pharmaceuticals Recent Developments/Updates
6.6 Dr.Reddy's Laboratories
6.6.1 Dr.Reddy's Laboratories Company Information
6.6.2 Dr.Reddy's Laboratories Description and Business Overview
6.6.3 Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.6.5 Dr.Reddy's Laboratories Recent Developments/Updates
6.7 Emcure Pharmaceuticals
6.7.1 Emcure Pharmaceuticals Company Information
6.7.2 Emcure Pharmaceuticals Description and Business Overview
6.7.3 Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.7.5 Emcure Pharmaceuticals Recent Developments/Updates
6.8 Intas Pharmaceuticals
6.8.1 Intas Pharmaceuticals Company Information
6.8.2 Intas Pharmaceuticals Description and Business Overview
6.8.3 Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.8.5 Intas Pharmaceuticals Recent Developments/Updates
6.9 Kyowa Kirin
6.9.1 Kyowa Kirin Company Information
6.9.2 Kyowa Kirin Description and Business Overview
6.9.3 Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.9.5 Kyowa Kirin Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Reliance Life Sciences
6.12.1 Reliance Life Sciences Company Information
6.12.2 Reliance Life Sciences Description and Business Overview
6.12.3 Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.12.5 Reliance Life Sciences Recent Developments/Updates
6.13 Harbin Pharmaceutical
6.13.1 Harbin Pharmaceutical Company Information
6.13.2 Harbin Pharmaceutical Description and Business Overview
6.13.3 Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.13.5 Harbin Pharmaceutical Recent Developments/Updates
6.14 North China Pharmaceutical
6.14.1 North China Pharmaceutical Company Information
6.14.2 North China Pharmaceutical Description and Business Overview
6.14.3 North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.14.5 North China Pharmaceutical Recent Developments/Updates
6.15 Jiuyuan Gene
6.15.1 Jiuyuan Gene Company Information
6.15.2 Jiuyuan Gene Description and Business Overview
6.15.3 Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.15.5 Jiuyuan Gene Recent Developments/Updates
6.16 Kexing Biopharm
6.16.1 Kexing Biopharm Company Information
6.16.2 Kexing Biopharm Description and Business Overview
6.16.3 Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.16.5 Kexing Biopharm Recent Developments/Updates
6.17 Qilu Pharmaceutical
6.17.1 Qilu Pharmaceutical Company Information
6.17.2 Qilu Pharmaceutical Description and Business Overview
6.17.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.17.5 Qilu Pharmaceutical Recent Developments/Updates
6.18 Quangang Pharmaceutical
6.18.1 Quangang Pharmaceutical Company Information
6.18.2 Quangang Pharmaceutical Description and Business Overview
6.18.3 Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.18.5 Quangang Pharmaceutical Recent Developments/Updates
6.19 Sunway Biotech
6.19.1 Sunway Biotech Company Information
6.19.2 Sunway Biotech Description and Business Overview
6.19.3 Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.19.5 Sunway Biotech Recent Developments/Updates
6.20 SL Pharmaceutical
6.20.1 SL Pharmaceutical Company Information
6.20.2 SL Pharmaceutical Description and Business Overview
6.20.3 SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.20.4 SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.20.5 SL Pharmaceutical Recent Developments/Updates
6.21 Four Rings Bio-Pharmaceutical
6.21.1 Four Rings Bio-Pharmaceutical Company Information
6.21.2 Four Rings Bio-Pharmaceutical Description and Business Overview
6.21.3 Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.21.5 Four Rings Bio-Pharmaceutical Recent Developments/Updates
6.22 Amoytop
6.22.1 Amoytop Company Information
6.22.2 Amoytop Description and Business Overview
6.22.3 Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.22.5 Amoytop Recent Developments/Updates
6.23 Wuzhong Pharmaceutical
6.23.1 Wuzhong Pharmaceutical Company Information
6.23.2 Wuzhong Pharmaceutical Description and Business Overview
6.23.3 Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Portfolio
6.23.5 Wuzhong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Industry Chain Analysis
7.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Production Mode & Process Analysis
7.4 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales and Marketing
7.4.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Channels
7.4.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Distributors
7.5 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Customer Analysis
8 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Dynamics
8.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Industry Trends
8.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Drivers
8.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Challenges
8.4 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott
Amgen Inc
Biocon Ltd.
Cadila Pharmaceuticals
Dr. Reddy’s Laboratories
Emcure Pharmaceuticals
Intas Pharmaceuticals
Kyowa Kirin
Novartis
Pfizer Inc
Reliance Life Sciences
Harbin Pharmaceutical
North China Pharmaceutical
Kexing Biopharm
Qilu Pharmaceutical
Quangang Pharmaceutical
Sunway Biotech
SL Pharmaceutical
Four Rings Bio-Pharmaceutical
Amoytop
Wuzhong Pharmaceutical
Arven Pharmaceuticals
Jiuyuan Gene
List of Tables
 Table 1. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2020-2025) & (K L)
 Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2026-2031) & (K L)
 Table 20. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2025) & (K L)
 Table 27. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2026-2031) & (K L)
 Table 28. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2025) & (K L)
 Table 32. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2026-2031) & (K L)
 Table 33. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2020-2025) & (K L)
 Table 37. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2026-2031) & (K L)
 Table 38. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2025) & (K L)
 Table 42. Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2026-2031) & (K L)
 Table 43. Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2020-2025) & (K L)
 Table 47. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2026-2031) & (K L)
 Table 48. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L) by Type (2020-2025)
 Table 51. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L) by Type (2026-2031)
 Table 52. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price (US$/L) by Type (2020-2025)
 Table 59. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price (US$/L) by Type (2026-2031)
 Table 60. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L) by Application (2020-2025)
 Table 61. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L) by Application (2026-2031)
 Table 62. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price (US$/L) by Application (2020-2025)
 Table 69. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price (US$/L) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Arven Pharmaceuticals Company Information
 Table 81. Arven Pharmaceuticals Description and Business Overview
 Table 82. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 84. Arven Pharmaceuticals Recent Developments/Updates
 Table 85. Biocon Company Information
 Table 86. Biocon Description and Business Overview
 Table 87. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 88. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 89. Biocon Recent Developments/Updates
 Table 90. Cadila Pharmaceuticals Company Information
 Table 91. Cadila Pharmaceuticals Description and Business Overview
 Table 92. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 93. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 94. Cadila Pharmaceuticals Recent Developments/Updates
 Table 95. Dr.Reddy's Laboratories Company Information
 Table 96. Dr.Reddy's Laboratories Description and Business Overview
 Table 97. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 98. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 99. Dr.Reddy's Laboratories Recent Developments/Updates
 Table 100. Emcure Pharmaceuticals Company Information
 Table 101. Emcure Pharmaceuticals Description and Business Overview
 Table 102. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 103. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 104. Emcure Pharmaceuticals Recent Developments/Updates
 Table 105. Intas Pharmaceuticals Company Information
 Table 106. Intas Pharmaceuticals Description and Business Overview
 Table 107. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 108. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 109. Intas Pharmaceuticals Recent Developments/Updates
 Table 110. Kyowa Kirin Company Information
 Table 111. Kyowa Kirin Description and Business Overview
 Table 112. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 113. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 114. Kyowa Kirin Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 118. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 123. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Reliance Life Sciences Company Information
 Table 126. Reliance Life Sciences Description and Business Overview
 Table 127. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 128. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 129. Reliance Life Sciences Recent Developments/Updates
 Table 130. Harbin Pharmaceutical Company Information
 Table 131. Harbin Pharmaceutical Description and Business Overview
 Table 132. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 133. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 134. Harbin Pharmaceutical Recent Developments/Updates
 Table 135. North China Pharmaceutical Company Information
 Table 136. North China Pharmaceutical Description and Business Overview
 Table 137. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 138. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 139. North China Pharmaceutical Recent Developments/Updates
 Table 140. Jiuyuan Gene Company Information
 Table 141. Jiuyuan Gene Description and Business Overview
 Table 142. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 143. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 144. Jiuyuan Gene Recent Developments/Updates
 Table 145. Kexing Biopharm Company Information
 Table 146. Kexing Biopharm Description and Business Overview
 Table 147. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 148. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 149. Kexing Biopharm Recent Developments/Updates
 Table 150. Qilu Pharmaceutical Company Information
 Table 151. Qilu Pharmaceutical Description and Business Overview
 Table 152. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 153. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 154. Qilu Pharmaceutical Recent Developments/Updates
 Table 155. Quangang Pharmaceutical Company Information
 Table 156. Quangang Pharmaceutical Description and Business Overview
 Table 157. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 158. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 159. Quangang Pharmaceutical Recent Developments/Updates
 Table 160. Sunway Biotech Company Information
 Table 161. Sunway Biotech Description and Business Overview
 Table 162. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 163. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 164. Sunway Biotech Recent Developments/Updates
 Table 165. SL Pharmaceutical Company Information
 Table 166. SL Pharmaceutical Description and Business Overview
 Table 167. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 168. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 169. SL Pharmaceutical Recent Developments/Updates
 Table 170. Four Rings Bio-Pharmaceutical Company Information
 Table 171. Four Rings Bio-Pharmaceutical Description and Business Overview
 Table 172. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 173. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 174. Four Rings Bio-Pharmaceutical Recent Developments/Updates
 Table 175. Amoytop Company Information
 Table 176. Amoytop Description and Business Overview
 Table 177. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 178. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 179. Amoytop Recent Developments/Updates
 Table 180. Wuzhong Pharmaceutical Company Information
 Table 181. Wuzhong Pharmaceutical Description and Business Overview
 Table 182. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 183. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product
 Table 184. Wuzhong Pharmaceutical Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Distributors List
 Table 188. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Customers List
 Table 189. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Trends
 Table 190. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Drivers
 Table 191. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Challenges
 Table 192. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)
 Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Type: 2024 & 2031
 Figure 4. Vials Product Picture
 Figure 5. Prefilled Product Picture
 Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Application: 2024 & 2031
 Figure 8. Myelosuppressive Chemotherapy
 Figure 9. Leukemia Chemotherapy
 Figure 10. Others
 Figure 11. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (2020-2031) & (K L)
 Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Average Price (US$/L) & (2020-2031)
 Figure 15. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Report Years Considered
 Figure 16. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Players: Market Share by Revenue in Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) in 2024
 Figure 19. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Type (2020-2031)
 Figure 56. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price (US$/L) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Application (2020-2031)
 Figure 59. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price (US$/L) by Application (2020-2031)
 Figure 60. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global PEG rhG CSF Market Research Report 2025
Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024
Global Recombinant Human GM CSF for Injection Market Research Report 2024
Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024
Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2024
Myeloid Cells Targeting Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global PEGylated Granulocyte Colony Stimulating Factor Market Research Report 2024
Global Recombinant Human Interferon α2a for Injection Market Research Report 2025
Global Recombinant Protein Drug R D Market Research Report 2024
Global Cellular and Gene Therapy Product Market Research Report 2025
Global Regenerative Injection Market Research Report 2025
Human Growth Hormone Deficiency Ghd Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recurrent Glioblastoma Multiforme Treatment Market Research Report 2025
Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rotating Gamma System RGS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Graft versus host Disease cGVHD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Epirubicin Hydrochloride Injection Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions